Assessing Disease Outcome Measures in Bullous Pemphigoid on Standard-Of-Care Therapies.

There were no differences in BPDAI TAS, BPDAI PCS, BP180, or BP230 by clinical status at baseline or month 4; patients who did not achieve P/C remission trended toward higher BPDAI TAS scores at month 4, although this did not reach statistical significance ( Table 2 ).

also in 111,027 other papers